What was once only a dream has become a reality– the Midwest Stem Cell Therapy Center at the University of Kansas Medical Center will host its inaugural in-depth educational conference about adult stem cell treatments Saturday, Nov. 23 in Kansas City. See details here.
The purpose of this conference (which provides continuing education credits) is to update health professionals and trainees about advances in therapy with adult stem cells, as well as explaining adult stem cell biology and its potential for tissue and organ regeneration.
Adult stem cell treatments in the form of bone marrow transplants have been used for many years to successfully treat leukemia and related bone/blood cancers. The scientific community is now focusing on additional therapeutic options including organ repair. The Midwest Stem Cell Therapy Center was created this year by the Kansas Legislature, (read here) under the leadership of Gov. Sam Brownback and Sen. Mary Pilcher-Cook, in order to:
- facilitate the “translation” of basic stem cell research findings into actual clinical applications;
- multiply clinical grade stem cells obtained from adult tissues, cord blood, and other sources, excluding embryonic and fetal;
- increase the number of patients receiving stem cell treatments;
- educate medical professionals and the public;
- create and maintain a global database of available stem cell trials and therapies.
The Center’s director is Buddhadeb Dawn, M.D., current director of the KU Med Center’s Cardiovascular Division, who has been engaged in promising adult stem cell therapy for cardiac repair. International stem cell expert, Dr. David A Prentice, has been appointed to the Center’s 15-member advisory board.
Let your favorite medical personnel know about this exciting conference!